Clinical efficacy and safety of tocilizumab in the treatment of seropositive rheumatoid arthritis patients in India
Background: Tocilizumab (TCZ) is a human interleukin (IL)-6 receptor (IL-6R) antibody which competitively inhibits IL-6 signal transduction. Clinical efficacy and safety of TCZ in the treatment of rheumatoid arthritis (RA) and other autoimmune conditions have been established. However, there is a la...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2020-01-01
|
| coleção: | Indian Journal of Rheumatology |
| Assuntos: | |
| Acesso em linha: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=4;spage=286;epage=291;aulast=Kumar |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
